Renosome Bio, Inc. — Form D

Renosome Bio, Inc. of MANCHESTER, CT, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-23. The offering totals $1.0M, of which $150K was reported sold. Industry: Biotechnology.

Offering

• Filed: 2024-10-23
• Form: D
• Accession: 0002040026-24-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $1.0M
• Amount sold: $150K
• Remaining: $850K
• Investors: 5
• Date of first sale: 2024-10-08
• Security types: debt
• Revenue range: Decline to Disclose
• SEC file number: 021-527630

Issuer

• Name: Renosome Bio, Inc.
• CIK: 0002040026
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2024
• Address: 69 COUGAR DR., MANCHESTER, CT, 06040
• Phone: (959) 333-5666

Officers, directors & promoters (2)

More

• CIK 2040026 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search